Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000912057-15-000123
Filing Date
2015-05-14
Accepted
2015-05-13 19:43:46
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1962741
2 GRAPHIC g187130.jpg GRAPHIC 25644
3 GRAPHIC g207195.jpg GRAPHIC 27986
4 GRAPHIC g346697.jpg GRAPHIC 25025
5 GRAPHIC g446524.jpg GRAPHIC 24356
6 GRAPHIC g466039.jpg GRAPHIC 27916
7 GRAPHIC g481731.jpg GRAPHIC 27962
8 GRAPHIC g584309.jpg GRAPHIC 27434
9 GRAPHIC g618484.jpg GRAPHIC 26975
10 GRAPHIC g636962.jpg GRAPHIC 30846
11 GRAPHIC g745336.jpg GRAPHIC 32273
12 GRAPHIC g780117.jpg GRAPHIC 27560
13 GRAPHIC g783035.jpg GRAPHIC 29589
14 GRAPHIC g905133.jpg GRAPHIC 30635
15 GRAPHIC g920963.jpg GRAPHIC 56038
16 GRAPHIC g945462.jpg GRAPHIC 74204
  Complete submission text file 0000912057-15-000123.txt   2644146
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-00970 | Film No.: 15859911
SIC: 2834 Pharmaceutical Preparations